Damora Therapeutics Inc. – Filings and Transcripts

NASDAQ: DMRA
Share price (11/6/26): $23.70
Market cap (11/6/26): $1.467 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/26 Q3

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Post-effective amendment to an automatic shelf registration

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Jarrett Jennifer

News Filter

Announces Redomestication From Delaware to Cayman Islands

Shareholder Vote Results

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Change in Certifying Accountant, Financial Statements or Exhibits

Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors

Proxies Filter

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Scanned paper annual report submission